Applications of N-Acetyl-DL-Norleucine in Industrial Manufacturing

As the manufacturer of N-Acetyl-DL-Norleucine, we supply this specialty amino acid derivative to numerous industrial segments requiring high purity, consistent batch performance, and compliance with global regulatory standards. Below are the key application scenarios where N-Acetyl-DL-Norleucine provides functional and process-related value to our customers’ manufacturing workflows.

1. Active Pharmaceutical Ingredient Synthesis (API Intermediates)

N-Acetyl-DL-Norleucine functions as a pivotal intermediate for peptide-based drug synthesis within cGMP-regulated pharmaceutical environments. Formulators employ it for solid-phase peptide synthesis where side-chain-protected amino acids are critical to defining sequence fidelity, stereochemical consistency, and batch reproducibility. Its non-canonical structure enables the design of peptides with modified backbone stability, supporting advanced research and commercial peptide drug manufacturing.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) Peptide Substrates Monographs
• US FDA 21 CFR Part 211 – cGMP for Finished Pharmaceuticals
• Japanese Pharmacopoeia General Rules

Typical usage ratio

• 0.5–3% molar incorporation per peptide chain length, based on target sequence and endpoint pharmacological profile

Downstream process integration

• Incorporated during the resin-bound peptide elongation stage, after initial coupling reagents and prior to cleavage of final product

Final product types

• Therapeutic peptides (injectables, lyophilized powders)
• Investigational peptide drugs
• Specialty diagnostic peptide kits

2. Diagnostic Reagent & Chromatography Stationary Phase Manufacturing

Downstream reagent manufacturers utilize N-Acetyl-DL-Norleucine as a calibrant and as a ligand for derivatization in specialty chromatography columns. Its unique chain structure enables separation of amino acid isomers and supports batch control in QC for medical diagnostic kits. Major reagent suppliers adopt stringent analytical validation using our pharmaceutical-grade N-Acetyl-DL-Norleucine when producing stationary phases for HPLC and LC-MS systems.

Industry compliance standards

• ISO 13485:2016 Medical Device Quality Management for diagnostic reagent production
• EN ISO 17025 Laboratory Accreditation for analytical standards
• Sigma-Aldrich Amino Acid Reagent Listing Specifications

Typical usage ratio

• 5–25 mg per chromatography column, depending on required calibration curve and sample throughput

Downstream process integration

• Immobilized on silica or polymeric carriers during stationary phase synthesis, or added as a reference in reagent QC batching

Final product types

• Analytical HPLC and LC-MS columns
• Diagnostic calibration standards
• Certified reference materials for amino acid analysis

3. Chemical Synthesis of Modified Peptides for Research & Development

Chemical research laboratories and industrial peptide manufacturers source N-Acetyl-DL-Norleucine for synthesizing non-natural peptides and peptide analogues, facilitating structure–activity relationship (SAR) studies and in vitro assay validation. Because of its acetylated α-amino group, it introduces chain rigidity and can influence peptide bioavailability or receptor selectivity—qualities essential for preclinical research and drug lead optimization.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP) for chemical research
• ISO 9001:2015 Quality Management Systems for laboratory reagents
• REACH Registration (EC No. 1907/2006) for specialty chemicals

Typical usage ratio

• Variable: 1–5% molar fraction of total amino acid content, subject to project-specific SAR design and bioassay strategy

Downstream process integration

• Enters pre-synthesis solution phase or directly loaded onto automated solid-phase peptide synthesizers

Final product types

• Custom peptide libraries
• SAR testing analogues
• Modified peptide fragments for bioanalytical R&D kits

4. Nutritional Formulations for Animal Feed Additives Research

In advanced animal nutrition R&D, feed manufacturers investigate N-Acetyl-DL-Norleucine as a designer amino acid to model essential amino acid substitution and digestibility in non-human food chains. As its acetylated nature is not found in typical animal proteins, its inclusion provides insight into protein assimilation and metabolic utilization, especially in monogastric and aquaculture species research applications.

Industry compliance standards

• EFSA Guidance for Feed Additives (Regulation (EC) No 1831/2003)
• ISO 22000 Food Safety Management Systems for animal feed
• AACo Feed Ingredient GMP+ B1 Certification

Typical usage ratio

• 0.02–0.1% of total feed formulation, typically evaluated in controlled experimental diets for metabolic studies

Downstream process integration

• Added into premix blending stage prior to pelleting or extrusion of compound feeds

Final product types

• Experimental feed blocks
• Modelled amino acid premixes
• Research diets for aquaculture and livestock trial programs

5. Specialty Biochemical Substrate Production

Manufacturers of biochemical substrates for enzyme kinetics and metabolic pathway investigations incorporate N-Acetyl-DL-Norleucine as a non-standard substrate for in vitro testing. Its tailored structure enables researchers to probe enzyme specificity or simulate rare metabolic steps in controlled laboratory settings, especially in studies targeting non-proteinogenic amino acid metabolism across various species.

Industry compliance standards

• GLP Certification (OECD, FDA)
• ISO 17034 Reference Material Producers Accreditation
• European Chemicals Agency (ECHA) Notification for Research Use Only (RUO) materials

Typical usage ratio

• 0.1–2 mM substrate concentration in assay buffer, optimized per enzyme system or metabolic experiment protocol

Downstream process integration

• Dosed directly into reaction vessels during in vitro enzyme assay setup, post-buffer preparation

Final product types

• Enzyme assay kits
• Biochemical diagnostic enzyme substrates
• Metabolic profiling reagents for laboratory research